General Insomnia Disorder in Adults and Treatment Guidelines is organized by Alaska Pharmacists Association (AKPhA). This Conference has been approved for a maximum of 1.5 CPE hours.

Release Date:  9/15/17
Expiration Date:  9/15/20

Course Description:
Insomnia is a common complaint among many adults in the U.S. Sleep insufficiency represents a significant burden on both the healthcare system and the economy. Excessive daytime sleepiness has been associated with increased motor vehicle accidents, occupational errors, and workplace hazards. Common characteristics of patients who develop insomnia include female sex, increased age, comorbid medical and/or psychiatric conditions, certain medications, shift work, and possibly unemployment and lower socioeconomic status.

A common approach to treatment of insomnia includes a combination of cognitive behavioral therapy and pharmacologic treatment. Cognitive behavioral therapy relies on addressing a patient’s thoughts and behaviors regarding sleep, whereas pharmacologic treatment aims to resolve the overall lack of sleep by utilizing appropriate medication therapy. Several pharmacologic agents have been approved by FDA for the indication of treating insomnia. There are many other pharmacologic agents, however, that while not currently indicated for treating insomnia, may be useful in certain patient populations, according to the American Academy of Sleep Medicine. Pharmacists should be aware of risk factors for development of insomnia, clinical presentation, and potential adverse effects of the various classes of medications commonly prescribed to treat insomnia.

At the completion of this activity, the participant will be able to:
• demonstrate an understanding of the scope of insomnia and its effects on both the economy and the healthcare system;
• recognize common risk factors and clinical presentation associated with insomnia;
• list non-pharmacologic strategies for treating insomnia; and
• demonstrate an understanding of pharmacologic agents used in the treatment of insomnia.

Intended Audience

Psychiatry, Sleep Medicine

Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


Alaska Pharmacists Association (AKPhA)

View Organizer Details